вторник, 14 февраля 2017 г.

Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb

Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb


But Bristol-Myers Squibb's stock is down over the last 12 months, while Exelixis' shares have soared. Which of these two biopharmaceutical is stocks is the better pick for investors now? Here's how Exelixis and Bristol-Myers Squibb compare.



from Biotech News